Clinical

Dataset Information

0

Personalized use of irinotecan in colorectal cancer patients based on real world studies and pharmacogenomics


ABSTRACT: Interventions: Wild-type group:None;Single heterozygous group:None;Mutant homozygous/double heterozygous group:None Primary outcome(s): Efficacy;The incidence of adverse events Study Design: Cohort study

DISEASE(S): Colorectal Cancer

PROVIDER: 89703 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2616019 | ecrin-mdr-crc
| 2620216 | ecrin-mdr-crc
| S-EPMC4920853 | biostudies-other
| S-EPMC3660037 | biostudies-literature
| S-EPMC7982063 | biostudies-literature
2016-01-06 | GSE76526 | GEO
| S-EPMC3513203 | biostudies-literature
| S-EPMC10137111 | biostudies-literature
| S-EPMC5944086 | biostudies-other
| S-EPMC10455985 | biostudies-literature